CVE-2000-1214

CVE-2000-1214 is a medium-severity vulnerability in Immunix with a CVSS 2.0 base score of 4.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Buffer overflows in the (1) outpack or (2) buf variables of ping in iputils before 20001010, as distributed on Red Hat Linux 6.2 through 7J and other operating systems, may allow local users to gain privileges.

Frequently asked questions

What is CVE-2000-1214?
Buffer overflows in the (1) outpack or (2) buf variables of ping in iputils before 20001010, as distributed on Red Hat Linux 6.2 through 7J and other operating systems, may allow local users to gain privileges.
How severe is CVE-2000-1214?
CVE-2000-1214 has a CVSS 2.0 base score of 4.6, rated medium severity.
Is CVE-2000-1214 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (33rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2000-1214?
CVE-2000-1214 primarily affects Immunix. In total, 6 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2000-1214?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2000-1214 published?
CVE-2000-1214 was published on 2000-10-18 and last updated on 2026-06-16.

References

Affected products (6)

More vulnerabilities in Immunix

All CVEs affecting Immunix →